Abortifacient effect of decreased decidual and placental galectin-1 expression due to metoclopramide exposure in pregnant rats

Cekmez Y., Korkmaz V., Çakır A., Göçmen A., Ergün Y., Gülşen S.

Journal of Reproductive Medicine, cilt.62, sa.4, ss.427-431, 2017 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 62 Sayı: 4
  • Basım Tarihi: 2017
  • Dergi Adı: Journal of Reproductive Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.427-431
  • Anahtar Kelimeler: abnormalities, drug-induced/epidemiology, abortifacient agents, abortifacients, abortion, antiemetics/adverse effects, decidua, fetal death/chemically induced, Galectin-1, metoclopramide, metoclopramide/adverse effects, pregnancy, teratogens, trophoblasts
  • İstanbul Medipol Üniversitesi Adresli: Evet

Özet

OBJECTIVE: To investigate the abortifacient effect of metoclopramide on decidual and trophoblastic tissues with immunohistochemical investigation of galectin-1 expression in pregnant rats. STUDY DESIGN: A total of 24 pregnant rats were selected for the study and divided into 3 groups as untreated, low-dose (1 mg/kg) metoclopramide applied, and high-dose (3 mg/kg) metoclopramide applied from days 5-15 of pregnancy. All rats were laparotomized on day 19 of pregnancy, and number of implantation sites, resorption, and dead or alive fetuses were recorded for evaluating abortifacient activity. Galectin-1 expression was investigated from decidual and trophoblastic tissues via immunohistochemical staining. RESULTS: The mean percentage of abortion was detected higher in the high-dose group than both control and low-dose groups. Galectin-1 staining was more intense and universal in the untreated group than both high- and low-dose metoclopramide exposed groups in labyrinth trophoblasts and decidual tissue. CONCLUSION: Metoclopramide exposure, especially in high doses, may cause abortion, and this drug should be recommended for use during pregnancy only when the benefit outweighs the risk.